Evidence map›Paper›PMID 35796012›Full record

SynthesisHaematologica2022

Association of FLT3-internal tandem duplication length with overall survival in acute myeloid leukemia: a systematic review and meta-analysis.

Tobias B Polak, Joost Van Rosmalen, Stijn Dirven, Julia K Herzig, Jacqueline Cloos, Soheil Meshinchi, Konstanze Döhner, Jeroen J W M Janssen, David G J Cucchi

Abstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Haematologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. FLT3-Mutated AML: Transplanting with Precision in the Targeted Era.Current hematologic malignancy reports · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Comment on Association ofHaematologica · 2023
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Tobias B PolakErasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands; Department of Biostatistics, Erasmus University Rotterdam, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus University Rotterdam, Rotterdam, The Netherlands; Real-World Data Department, myTomorrows, Amsterdam.
Joost Van RosmalenDepartment of Biostatistics, Erasmus University Rotterdam, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus University Rotterdam, Rotterdam.
Stijn DirvenDepartment of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, location VUmc, Amsterdam.
Julia K HerzigDepartment of Internal Medicine III, University Hospital of Ulm, Ulm.
Jacqueline CloosDepartment of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, location VUmc, Amsterdam.
Soheil MeshinchiClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Konstanze DöhnerDepartment of Internal Medicine III, University Hospital of Ulm, Ulm.
Jeroen J W M JanssenDepartment of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, location VUmc, Amsterdam.
David G J CucchiDepartment of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, location VUmc, Amsterdam. d.cucchi@amsterdamumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, Acutefms-Like Tyrosine Kinase 3Gene DuplicationHumansMutationPrognosisTandem Repeat SequencesFLT3 protein, humanfms-Like Tyrosine Kinase 3

Identifiers

PMID35796012
PMCPMC9521221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.